Chain Pharmacy

FDA approves Lucinactant and Peginesatide

Readers call for more foreign reports, point out that the ivory tower is nothing like retail, and inveigh against mail order

Watch out for pharmacists who have had enough: They can find some imaginative ways of registering their dissatisfaction

Who says the pharmacist's role has changed over the years? Haven't we always helped patients with their dead sea creatures?

Pharmacists who practice cultural awareness can deliver better patient care and bring about better outcomes

A final ruling from CMS states that "We now believe a more targeted and less disruptive approach is warranted"

Okay, pharmacists. All together now. What's the one question you hear all day long?

Experts gave tips on helping prevent crimes focused on retail pharmacy during Protect Your Pharmacy Week in late April

Five men, five different careers: all driven by a common passion for pharmacy

A round-up of apps that can improve the pharmacy bottom line and help with patient care

Because their classification is variable, the taxation of glucose test strips varies from state to state, giving rise to massive confusion and loss of revenue

Ned Milenkovich has been reappointed to the Illinois State Board of Pharmacy for an additional five-year term

As drug reimbursement policies change, one question keeps popping up. What will replace average wholesale price?

NABP has launched an initiative to transfer prescription monitoring program information across state lines

The time has come for pharmacists to work on reforming the maximum allowable costs put forth by the pharmacy benefit managers

A survey of new Rx, new generic, and new OTC products

A round-up of OTC products to help manage skin problems

Connecticut's recently enacted law legalizing medical marijuana includes language ensuring that pharmacists who follow state law will be protected from prosecution

A recent study indicated that the cost of diabetes treatment could be reduced if physicians prescribed more generics

Afatinib used in lung cancer treatment helped patients live longer, according to the results of a new phase 3 clinical trial.

Men with advanced prostate cancer treated with enzalutamide (formerly MDV3100) demonstrated a significantly higher response rate in health-related quality of life, according to new data from the phase 3 AFFIRM study.

Label prescribing information for dabigatran (Pradaxa, Boehringer Ingelheim) capsules has been updated to affirm that the 150-mg twice-daily dose is superior to warfarin in reducing ischemic and hemorrhagic strokes in patients with nonvalvular atrial fibrillation.

U.S. Marshals recently seized misbranded Global Biotechnologies dietary supplements at the request of the FDA, and per a warrant issued by the U.S. District Court for the District of Maine, according to an FDA statement.

Nonsteroidal anti-inflammatory drugs (NSAIDs) may prevent the development of skin cancer, according to a new study, published online first in the journal Cancer on May 29.

With the help of the National Community Pharmacists Association, community pharmacists are taking on the issue of medication nonadherence, which costs the nation about $300 billion each year, the organization announced in a recent statement.

The industry should collaborate to develop a U.S. Biopharmacopeia Registry of Biopharmaceutical Products to help resolve biosimilar and broader biopharmaceutical nomenclature issues, according to a leading author and publisher.

The Centers for Medicare & Medicaid Services is partnering with providers, caregivers, and patients to ensure appropriate use of antipsychotic medications for nursing home patients, the government announced last week.

The Obama administration?s plan to close the racial and ethnic gap on childhood asthma has drawn strong support from the Merck Childhood Asthma Network.

Intensive control of blood-sugar levels among patients with type 2 diabetes mellitus may reduce the risk of microalbuminuria and macroalbuminuria, signs of kidney damage, but evidence is lacking regarding the effect over renal end points, according to the results of a study published May 28 in Archives of Internal Medicine.

Patients taking statins for the first time demonstrated better medication adherence if they participated in face-to-face counseling sessions with a community pharmacist than patients who did not, according to a new study by Walgreens.